Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29

COVIDIEN PLC (COV)

21
Delayed Quote. Delayed Nyse - 09/17 04:00:32 pm
91.15 USD   -0.56%
5h ago COVIDIEN : Announces Dividend Increase
1d ago Roche's $8 billion InterMune buy not a signal for more big deals
2d ago Danaher to buy Nobel Biocare for $2.2 billion
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/11/2014 09/12/2014 09/15/2014 09/16/2014 09/17/2014 Date
91.25(c) 90.67(c) 90.47(c) 91.66(c) 91.15(c) Last
1 990 001 2 052 813 1 278 373 1 842 751 4 017 305 Volume
+0.20% -0.64% -0.22% +1.32% -0.56% Change
More quotes
Company
Covidien Plc engages in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates through three segments: Medical Devices, Pharmaceuticals and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of... 
Surperformance© rating of Covidien plc
Trading Rating : Investor Rating :
More about the company
Chart COVIDIEN PLC
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 10 611 M
EBIT 2014 2 376 M
Net income 2014 1 641 M
Debt 2014 3 202 M
Yield 2014 1,35%
Sales 2015 11 119 M
EBIT 2015 2 563 M
Net income 2015 1 982 M
Debt 2015 2 062 M
Yield 2015 1,43%
PER 2014 25,53
PER 2015 20,80
EV / Sales 2014 4,20x
EV / Sales 2015 3,91x
Capitalization 41 408 M
More Financials
Latest news on COVIDIEN PLC
5h ago COVIDIEN : Announces Dividend Increase
1d ago Roche's $8 billion InterMune buy not a signal for more big deals
2d ago Danaher to buy Nobel Biocare for $2.2 billion
2d ago Danaher to buy Nobel Biocare for $2.2 billion
2d ago COVIDIEN : Announces Start of Enrollment in Two Neurovascular Clinical Trials
2d agoDJDanaher Buys Nobel Biocare in $2.1 Billion Cash Deal
09/05 COVIDIEN : Upcoming Conferences, Dividends, Regulatory Disclosures, and Acquisit..
08/28 COVIDIEN : Acquires Venous Disease Treatment Developer Sapheon, Inc.
08/26 COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
08/26DJMedtronic Buys Brain-Stimulation Firm
08/26DJMedtronic Buys Brain-Stimulation Firm for $200 Million
08/25 Roche to buy U.S. biotech firm InterMune for $8.3 billion
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Covidien plc : Income Statement Evolution
More Financials
EPS Revisions
Covidien plc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF